To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

NCT04024072 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

495

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Brinzolamide 1% ophthalmic suspension
DRUG: Azopt 1% Ophthalmic Suspension

Sponsor

Padagis LLC